TB-500 Peptide for Injury Repair: An Alternative to BPC-157
When it comes to peptide therapy, the spotlight has recently shifted toward TB-500, a promising alternative to the now-regulated peptide, BPC-157. The regulatory changes surrounding BPC-157 have prompted many patients who used it for injury repair to explore other options. TB-500, known scientifically as a derivative of Thymosin Beta-4, has